Claudin 18.2 x CD3
Assets acting on this target.
- Class
- Bispecific antibody
Related mechanisms
Claudin 18.2 x CD3 drugs compared
2 drugs, stage by indication
| Drug | Developer | Modality | Furthest stage | Stage by indication |
|---|---|---|---|---|
| ASP2138 | Astellas Pharma | bispecific antibody | Phase 3 | Phase 3 in Gastric Cancer |
| AZD5863 | AstraZeneca | bispecific antibody | Stage not recorded | Not recorded |